Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis

EDUARDO AGÜERA MORALESINMACULADA TASSET CUEVAS2026-01-292026-01-29201310.1016/S1734-1140(13)71039-92-s2.0-84884495677https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/24821PharmacologyEffect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosisresearch article